CN Stock MarketDetailed Quotes

000766 Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Watchlist

15.45
-0.25-1.59%

Market Closed Jan 2 15:00 CST

14.93BMarket Cap286.11P/E (TTM)

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

52.34%275.74M

15.51%264.64M

11.40%244.56M

-47.32%177.45M

-34.27%181.01M

-17.86%229.11M

-15.05%219.53M

11.68%336.82M

-19.07%275.38M

-27.28%278.91M

Transactional financial assets

885.93%1.07M

-2.51%113.22K

777.77%1.07M

716.68%1.05M

2.76%108.55K

-16.74%116.14K

-25.62%121.97K

-28.80%128.39K

--105.63K

--139.48K

Notes receivable and accounts receivable

13.60%483.42M

14.35%500.31M

38.25%508.53M

17.26%502.11M

10.62%425.56M

5.63%437.53M

-13.85%367.82M

22.11%428.19M

9.10%384.7M

1.10%414.2M

-Notes receivable

-98.63%47.88K

192.05%2.89M

4.52%3.22M

23.61%5.29M

14.38%3.49M

78.23%989.66K

--3.09M

8,459.85%4.28M

--3.05M

--555.28K

-Accounts receivable

14.53%483.37M

13.95%497.42M

38.54%505.3M

17.20%496.82M

10.59%422.06M

5.54%436.54M

-14.58%364.73M

20.91%423.91M

8.24%381.65M

0.97%413.64M

Other receivables (including interest and dividends)

-13.12%23.02M

-40.40%24.45M

4.74%48.02M

-2.63%34.81M

-49.77%26.49M

-35.50%41.03M

-16.36%45.85M

-23.91%35.75M

-25.04%52.74M

-24.62%63.61M

-Dividend receivable

----

--12.72M

-Other receivable

----

-40.40%24.45M

----

-19.37%41.03M

----

-23.91%35.75M

----

-39.70%50.89M

Advance payment

-45.12%7.94M

-30.60%8.72M

-4.60%11.12M

-41.39%8.03M

30.64%14.47M

-12.03%12.56M

-12.65%11.66M

106.52%13.71M

-7.20%11.08M

13.48%14.28M

Inventories

4.69%403.11M

3.18%390.23M

-4.24%385.05M

-3.20%369.17M

2.17%385.05M

2.81%378.22M

9.48%402.09M

-0.83%381.37M

-8.51%376.89M

-9.96%367.89M

Receivable financing

-2.16%15.82M

126.74%19.43M

-3.24%14.02M

-56.91%18.2M

15.04%16.17M

73.49%8.57M

-11.91%14.49M

-9.12%42.23M

-49.51%14.05M

-76.79%4.94M

Other current assets

50.43%242.94K

47.69%242.94K

-41.60%93.14K

141.48%397.2K

-92.47%161.5K

-96.19%164.49K

-98.71%159.49K

-98.87%164.49K

-88.72%2.15M

-79.98%4.32M

Total current assets

15.38%1.21B

9.11%1.21B

14.20%1.21B

-10.27%1.11B

-6.09%1.05B

-3.57%1.11B

-7.66%1.06B

7.53%1.24B

-9.47%1.12B

-14.41%1.15B

Non Current assets

Other equity investment

0.00%1.91B

Other non-current financial assets

0.00%18.77M

0.16%18.77M

Long-term equity investment

-3.84%55.25M

-0.77%53.32M

-6.01%53M

-6.63%52.68M

9.32%57.46M

-1.56%53.73M

2.32%56.39M

0.71%56.43M

-4.75%52.56M

-4.76%54.58M

Fixed assets

----

-4.15%713.87M

----

-5.59%744.75M

----

-5.41%767.03M

----

-4.90%788.82M

Constru in process

----

-1.83%269.28M

----

2.94%274.32M

----

3.18%267.39M

----

4.38%266.48M

Productive biological assets

1.60%17.11M

2.19%17M

18.77%16.96M

20.70%16.93M

25.44%16.84M

26.72%16.63M

9.77%14.28M

9.84%14.03M

6.26%13.42M

4.35%13.13M

Intangible assets

-8.15%188.95M

-7.12%193.25M

-6.85%197.72M

-6.90%201.67M

-6.60%205.71M

-7.40%208.06M

-7.32%212.27M

-7.19%216.61M

-7.03%220.26M

-6.90%224.68M

Development expenditure

11.22%185.02M

13.06%184.85M

7.60%173.96M

7.54%172.18M

5.50%166.35M

5.64%163.49M

4.58%161.67M

5.09%160.11M

7.23%157.67M

5.87%154.77M

Goodwill

0.00%1.9M

-0.38%1.9M

Long deferred expense

-31.96%943.88K

53.29%1.05M

59.03%1.17M

64.10%1.28M

68.62%1.39M

-20.69%688.08K

-20.97%732.95K

-18.75%777.83K

-18.17%822.7K

-17.76%867.58K

Deferred tax assets

-15.42%12.68M

-12.63%13.08M

-17.83%12.53M

-7.43%13.6M

-12.52%14.99M

-13.76%14.97M

-24.26%15.25M

-24.03%14.69M

-16.87%17.14M

-20.28%17.36M

Usufruct assets

70.47%3.08M

98.83%3.66M

20.85%4.25M

12.40%4.83M

-50.87%1.81M

-51.01%1.84M

-8.53%3.52M

9.44%4.3M

--3.68M

--3.76M

Other non current assets

64.87%16.57M

-46.82%7.16M

-33.16%6.97M

-44.18%5.85M

-0.48%10.05M

58.08%13.46M

27.77%10.43M

95.18%10.47M

-1.85%10.1M

-1.57%8.51M

Total non current assets

-0.87%3.39B

-1.03%3.39B

-1.34%3.39B

-1.12%3.41B

-1.09%3.42B

-1.18%3.43B

-1.33%3.44B

-1.21%3.45B

-1.11%3.45B

-1.16%3.47B

Total assets

2.94%4.6B

1.44%4.6B

2.32%4.61B

-3.54%4.52B

-2.31%4.47B

-1.78%4.53B

-2.90%4.5B

0.96%4.69B

-3.29%4.57B

-4.82%4.62B

Liabilities

Current liabilities

Short term loan

79.61%233.71M

80.38%234.71M

73.04%225.15M

419.77%130.16M

225.29%130.12M

-37.48%25.04M

-11.11%40M

Notes payable and accounts payable

-39.76%135.78M

-37.27%143.44M

-18.07%167.11M

-13.88%191M

38.33%225.4M

28.03%228.66M

25.17%203.98M

47.28%221.79M

0.10%162.94M

4.13%178.6M

-Notes payable

-12.13%7.27M

183.15%10.96M

22.90%7.1M

21.91%7.65M

65.32%8.27M

53.31%3.87M

200.88%5.78M

226.86%6.28M

1,329.48%5M

--2.52M

-Accounts payable

-40.81%128.52M

-41.07%132.48M

-19.27%160.01M

-14.92%183.35M

37.48%217.12M

27.67%224.79M

23.08%198.2M

44.96%215.51M

-2.76%157.94M

2.66%176.08M

Contract liabilities

-36.49%12.75M

-15.06%12.12M

-4.07%13.02M

-70.69%11.66M

103.65%20.08M

106.61%14.26M

40.86%13.58M

245.98%39.79M

-32.91%9.86M

-61.56%6.9M

Salaries payable

-7.01%16.5M

-11.21%15.98M

-3.27%16.92M

-24.21%17.05M

-5.15%17.75M

-5.56%17.99M

-8.12%17.49M

14.26%22.5M

-11.82%18.71M

12.78%19.06M

Taxs payable

-46.36%9.11M

-46.34%8.61M

6.94%12.94M

-34.91%20.37M

-24.62%16.98M

-30.72%16.04M

-40.75%12.1M

56.83%31.3M

117.98%22.52M

95.66%23.15M

Other payable (including interest and dividends)

114.86%215.31M

100.62%219.15M

87.84%196.89M

52.77%188.21M

-10.14%100.21M

-20.72%109.24M

-36.38%104.82M

-22.78%123.2M

-31.19%111.52M

-35.30%137.78M

-Dividend payable

0.00%3.59M

-Other payable

----

104.04%215.56M

----

-21.27%105.65M

----

-23.31%119.61M

----

-35.91%134.19M

Non current liabilities due within one year

9,752.14%7.47M

15,120.44%8.7M

--8.67M

-93.72%12.86M

-99.96%75.84K

-100.00%57.15K

----

-87.39%204.88M

-54.00%195.87M

972.80%1.78B

Other current liabilities

-30.42%972.59K

-29.02%782.99K

-33.73%853.3K

-65.13%1.17M

102.52%1.4M

120.38%1.1M

83.47%1.29M

187.38%3.37M

-43.00%690.23K

-60.96%500.57K

Total current liabilities

23.36%631.6M

24.35%643.48M

32.73%641.57M

-14.79%572.49M

-8.91%512M

-76.31%517.48M

-78.05%483.38M

-66.86%671.86M

-33.33%562.11M

239.58%2.18B

Current liabilities

Long term loan

-0.40%1.56B

0.21%1.57B

-0.40%1.56B

-0.78%1.56B

--1.56B

750.91%1.56B

6.74%1.58B

----

Deferred tax liabilities

-15.63%3.35M

7.57%3.87M

-2.80%4.14M

-11.72%4.36M

-26.60%3.97M

-41.14%3.59M

-37.39%4.26M

-32.38%4.94M

-28.80%5.41M

-24.91%6.11M

Long term deferred income

-7.77%61.43M

-8.96%62.22M

-10.09%63.01M

-9.85%64.75M

-9.60%66.6M

-9.38%68.34M

-9.07%70.08M

-8.96%71.83M

-8.64%73.67M

-8.98%75.41M

Lease liabilities

-11.26%2.06M

-9.03%2.16M

-47.00%2.14M

-51.76%2.14M

-41.75%2.32M

-39.67%2.37M

-5.02%4.03M

11.51%4.44M

--3.98M

--3.93M

Total non current liabilities

-0.75%1.62B

-0.75%1.63B

-0.35%1.64B

-0.98%1.63B

-1.35%1.64B

1,816.67%1.64B

1,763.23%1.64B

500.43%1.64B

6.03%1.66B

-95.45%85.45M

Total liabilities

5.00%2.26B

5.28%2.27B

7.17%2.28B

-4.99%2.2B

-3.27%2.15B

-5.04%2.16B

-7.19%2.13B

0.66%2.32B

-7.75%2.22B

-10.02%2.27B

Shareholders equity

Paid-in capital

0.00%966.49M

Capital reserve funds

-0.78%3.58B

-1.73%3.58B

-0.96%3.61B

0.00%3.64B

Surplus reserve funds

0.00%108.65M

Retained profit

2.21%-2.31B

1.93%-2.32B

1.94%-2.33B

1.85%-2.34B

1.39%-2.37B

1.30%-2.37B

1.25%-2.38B

1.31%-2.4B

0.82%-2.4B

Shareholders equity without minority interests

1.05%2.34B

-0.75%2.33B

-0.72%2.33B

-0.82%2.32B

-0.08%2.32B

1.44%2.35B

1.35%2.34B

1.31%2.34B

1.40%2.32B

0.86%2.31B

Minority interests

-14.40%405.17K

-98.89%347.33K

-98.59%443.77K

-98.53%464.26K

-98.51%473.31K

-3.05%31.17M

-3.08%31.4M

-2.95%31.64M

-3.03%31.87M

-3.21%32.15M

Total shareholder equity

1.04%2.34B

-2.03%2.33B

-2.02%2.33B

-2.13%2.32B

-1.41%2.32B

1.38%2.38B

1.29%2.38B

1.25%2.37B

1.33%2.35B

0.81%2.35B

Total liabilityies and equity

2.94%4.6B

1.44%4.6B

2.32%4.61B

-3.54%4.52B

-2.31%4.47B

-1.78%4.53B

-2.90%4.5B

0.96%4.69B

-3.29%4.57B

-4.82%4.62B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Zhongzhun Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	52.34%275.74M	15.51%264.64M	11.40%244.56M	-47.32%177.45M	-34.27%181.01M	-17.86%229.11M	-15.05%219.53M	11.68%336.82M	-19.07%275.38M	-27.28%278.91M
Transactional financial assets	885.93%1.07M	-2.51%113.22K	777.77%1.07M	716.68%1.05M	2.76%108.55K	-16.74%116.14K	-25.62%121.97K	-28.80%128.39K	--105.63K	--139.48K
Notes receivable and accounts receivable	13.60%483.42M	14.35%500.31M	38.25%508.53M	17.26%502.11M	10.62%425.56M	5.63%437.53M	-13.85%367.82M	22.11%428.19M	9.10%384.7M	1.10%414.2M
-Notes receivable	-98.63%47.88K	192.05%2.89M	4.52%3.22M	23.61%5.29M	14.38%3.49M	78.23%989.66K	--3.09M	8,459.85%4.28M	--3.05M	--555.28K
-Accounts receivable	14.53%483.37M	13.95%497.42M	38.54%505.3M	17.20%496.82M	10.59%422.06M	5.54%436.54M	-14.58%364.73M	20.91%423.91M	8.24%381.65M	0.97%413.64M
Other receivables (including interest and dividends)	-13.12%23.02M	-40.40%24.45M	4.74%48.02M	-2.63%34.81M	-49.77%26.49M	-35.50%41.03M	-16.36%45.85M	-23.91%35.75M	-25.04%52.74M	-24.62%63.61M
-Dividend receivable	----	----	----	----	----	----	----	----	----	--12.72M
-Other receivable	----	-40.40%24.45M	----	----	----	-19.37%41.03M	----	-23.91%35.75M	----	-39.70%50.89M
Advance payment	-45.12%7.94M	-30.60%8.72M	-4.60%11.12M	-41.39%8.03M	30.64%14.47M	-12.03%12.56M	-12.65%11.66M	106.52%13.71M	-7.20%11.08M	13.48%14.28M
Inventories	4.69%403.11M	3.18%390.23M	-4.24%385.05M	-3.20%369.17M	2.17%385.05M	2.81%378.22M	9.48%402.09M	-0.83%381.37M	-8.51%376.89M	-9.96%367.89M
Receivable financing	-2.16%15.82M	126.74%19.43M	-3.24%14.02M	-56.91%18.2M	15.04%16.17M	73.49%8.57M	-11.91%14.49M	-9.12%42.23M	-49.51%14.05M	-76.79%4.94M
Other current assets	50.43%242.94K	47.69%242.94K	-41.60%93.14K	141.48%397.2K	-92.47%161.5K	-96.19%164.49K	-98.71%159.49K	-98.87%164.49K	-88.72%2.15M	-79.98%4.32M
Total current assets	15.38%1.21B	9.11%1.21B	14.20%1.21B	-10.27%1.11B	-6.09%1.05B	-3.57%1.11B	-7.66%1.06B	7.53%1.24B	-9.47%1.12B	-14.41%1.15B
Non Current assets
Other equity investment	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B
Other non-current financial assets	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.16%18.77M	0.16%18.77M
Long-term equity investment	-3.84%55.25M	-0.77%53.32M	-6.01%53M	-6.63%52.68M	9.32%57.46M	-1.56%53.73M	2.32%56.39M	0.71%56.43M	-4.75%52.56M	-4.76%54.58M
Fixed assets	----	-4.15%713.87M	----	----	----	-5.59%744.75M	----	-5.41%767.03M	----	-4.90%788.82M
Constru in process	----	-1.83%269.28M	----	----	----	2.94%274.32M	----	3.18%267.39M	----	4.38%266.48M
Productive biological assets	1.60%17.11M	2.19%17M	18.77%16.96M	20.70%16.93M	25.44%16.84M	26.72%16.63M	9.77%14.28M	9.84%14.03M	6.26%13.42M	4.35%13.13M
Intangible assets	-8.15%188.95M	-7.12%193.25M	-6.85%197.72M	-6.90%201.67M	-6.60%205.71M	-7.40%208.06M	-7.32%212.27M	-7.19%216.61M	-7.03%220.26M	-6.90%224.68M
Development expenditure	11.22%185.02M	13.06%184.85M	7.60%173.96M	7.54%172.18M	5.50%166.35M	5.64%163.49M	4.58%161.67M	5.09%160.11M	7.23%157.67M	5.87%154.77M
Goodwill	0.00%1.9M	0.00%1.9M	0.00%1.9M	0.00%1.9M	0.00%1.9M	0.00%1.9M	-0.38%1.9M	-0.38%1.9M	-0.38%1.9M	-0.38%1.9M
Long deferred expense	-31.96%943.88K	53.29%1.05M	59.03%1.17M	64.10%1.28M	68.62%1.39M	-20.69%688.08K	-20.97%732.95K	-18.75%777.83K	-18.17%822.7K	-17.76%867.58K
Deferred tax assets	-15.42%12.68M	-12.63%13.08M	-17.83%12.53M	-7.43%13.6M	-12.52%14.99M	-13.76%14.97M	-24.26%15.25M	-24.03%14.69M	-16.87%17.14M	-20.28%17.36M
Usufruct assets	70.47%3.08M	98.83%3.66M	20.85%4.25M	12.40%4.83M	-50.87%1.81M	-51.01%1.84M	-8.53%3.52M	9.44%4.3M	--3.68M	--3.76M
Other non current assets	64.87%16.57M	-46.82%7.16M	-33.16%6.97M	-44.18%5.85M	-0.48%10.05M	58.08%13.46M	27.77%10.43M	95.18%10.47M	-1.85%10.1M	-1.57%8.51M
Total non current assets	-0.87%3.39B	-1.03%3.39B	-1.34%3.39B	-1.12%3.41B	-1.09%3.42B	-1.18%3.43B	-1.33%3.44B	-1.21%3.45B	-1.11%3.45B	-1.16%3.47B
Total assets	2.94%4.6B	1.44%4.6B	2.32%4.61B	-3.54%4.52B	-2.31%4.47B	-1.78%4.53B	-2.90%4.5B	0.96%4.69B	-3.29%4.57B	-4.82%4.62B
Liabilities
Current liabilities
Short term loan	79.61%233.71M	80.38%234.71M	73.04%225.15M	419.77%130.16M	225.29%130.12M	225.29%130.12M	225.29%130.12M	-37.48%25.04M	-11.11%40M	-11.11%40M
Notes payable and accounts payable	-39.76%135.78M	-37.27%143.44M	-18.07%167.11M	-13.88%191M	38.33%225.4M	28.03%228.66M	25.17%203.98M	47.28%221.79M	0.10%162.94M	4.13%178.6M
-Notes payable	-12.13%7.27M	183.15%10.96M	22.90%7.1M	21.91%7.65M	65.32%8.27M	53.31%3.87M	200.88%5.78M	226.86%6.28M	1,329.48%5M	--2.52M
-Accounts payable	-40.81%128.52M	-41.07%132.48M	-19.27%160.01M	-14.92%183.35M	37.48%217.12M	27.67%224.79M	23.08%198.2M	44.96%215.51M	-2.76%157.94M	2.66%176.08M
Contract liabilities	-36.49%12.75M	-15.06%12.12M	-4.07%13.02M	-70.69%11.66M	103.65%20.08M	106.61%14.26M	40.86%13.58M	245.98%39.79M	-32.91%9.86M	-61.56%6.9M
Salaries payable	-7.01%16.5M	-11.21%15.98M	-3.27%16.92M	-24.21%17.05M	-5.15%17.75M	-5.56%17.99M	-8.12%17.49M	14.26%22.5M	-11.82%18.71M	12.78%19.06M
Taxs payable	-46.36%9.11M	-46.34%8.61M	6.94%12.94M	-34.91%20.37M	-24.62%16.98M	-30.72%16.04M	-40.75%12.1M	56.83%31.3M	117.98%22.52M	95.66%23.15M
Other payable (including interest and dividends)	114.86%215.31M	100.62%219.15M	87.84%196.89M	52.77%188.21M	-10.14%100.21M	-20.72%109.24M	-36.38%104.82M	-22.78%123.2M	-31.19%111.52M	-35.30%137.78M
-Dividend payable	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M
-Other payable	----	104.04%215.56M	----	----	----	-21.27%105.65M	----	-23.31%119.61M	----	-35.91%134.19M
Non current liabilities due within one year	9,752.14%7.47M	15,120.44%8.7M	--8.67M	-93.72%12.86M	-99.96%75.84K	-100.00%57.15K	----	-87.39%204.88M	-54.00%195.87M	972.80%1.78B
Other current liabilities	-30.42%972.59K	-29.02%782.99K	-33.73%853.3K	-65.13%1.17M	102.52%1.4M	120.38%1.1M	83.47%1.29M	187.38%3.37M	-43.00%690.23K	-60.96%500.57K
Total current liabilities	23.36%631.6M	24.35%643.48M	32.73%641.57M	-14.79%572.49M	-8.91%512M	-76.31%517.48M	-78.05%483.38M	-66.86%671.86M	-33.33%562.11M	239.58%2.18B
Current liabilities
Long term loan	-0.40%1.56B	-0.40%1.56B	0.21%1.57B	-0.40%1.56B	-0.78%1.56B	--1.56B	--1.56B	750.91%1.56B	6.74%1.58B	----
Deferred tax liabilities	-15.63%3.35M	7.57%3.87M	-2.80%4.14M	-11.72%4.36M	-26.60%3.97M	-41.14%3.59M	-37.39%4.26M	-32.38%4.94M	-28.80%5.41M	-24.91%6.11M
Long term deferred income	-7.77%61.43M	-8.96%62.22M	-10.09%63.01M	-9.85%64.75M	-9.60%66.6M	-9.38%68.34M	-9.07%70.08M	-8.96%71.83M	-8.64%73.67M	-8.98%75.41M
Lease liabilities	-11.26%2.06M	-9.03%2.16M	-47.00%2.14M	-51.76%2.14M	-41.75%2.32M	-39.67%2.37M	-5.02%4.03M	11.51%4.44M	--3.98M	--3.93M
Total non current liabilities	-0.75%1.62B	-0.75%1.63B	-0.35%1.64B	-0.98%1.63B	-1.35%1.64B	1,816.67%1.64B	1,763.23%1.64B	500.43%1.64B	6.03%1.66B	-95.45%85.45M
Total liabilities	5.00%2.26B	5.28%2.27B	7.17%2.28B	-4.99%2.2B	-3.27%2.15B	-5.04%2.16B	-7.19%2.13B	0.66%2.32B	-7.75%2.22B	-10.02%2.27B
Shareholders equity
Paid-in capital	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M
Capital reserve funds	-0.78%3.58B	-1.73%3.58B	-1.73%3.58B	-1.73%3.58B	-0.96%3.61B	0.00%3.64B	0.00%3.64B	0.00%3.64B	0.00%3.64B	0.00%3.64B
Surplus reserve funds	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M
Retained profit	2.21%-2.31B	1.93%-2.32B	1.94%-2.33B	1.85%-2.34B	1.39%-2.37B	1.39%-2.37B	1.30%-2.37B	1.25%-2.38B	1.31%-2.4B	0.82%-2.4B
Shareholders equity without minority interests	1.05%2.34B	-0.75%2.33B	-0.72%2.33B	-0.82%2.32B	-0.08%2.32B	1.44%2.35B	1.35%2.34B	1.31%2.34B	1.40%2.32B	0.86%2.31B
Minority interests	-14.40%405.17K	-98.89%347.33K	-98.59%443.77K	-98.53%464.26K	-98.51%473.31K	-3.05%31.17M	-3.08%31.4M	-2.95%31.64M	-3.03%31.87M	-3.21%32.15M
Total shareholder equity	1.04%2.34B	-2.03%2.33B	-2.02%2.33B	-2.13%2.32B	-1.41%2.32B	1.38%2.38B	1.29%2.38B	1.25%2.37B	1.33%2.35B	0.81%2.35B
Total liabilityies and equity	2.94%4.6B	1.44%4.6B	2.32%4.61B	-3.54%4.52B	-2.31%4.47B	-1.78%4.53B	-2.90%4.5B	0.96%4.69B	-3.29%4.57B	-4.82%4.62B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Zhongzhun Certified Public Accountants (Special General Partnership)	--	--	--	Zhongzhun Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

Investment Theme

Innovative Drugs

Intraday-1.98%

Traditional Chinese Medicine Concept

Intraday-2.22%

Industrial Hemp

Intraday-2.24%

000766 Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow